Skip to content

Napp Pharmaceuticals Limited is a UK-based commercial pharmaceutical company, and we make medicines available to UK health professionals and their patients. Having a commercial focus on the UK market alone means that we have built enviable expertise in our healthcare system, and we have the flexibility to ensure that we can support the NHS in addressing its challenges whilst also securing our success and sustainability as a business.

Whilst our commercial focus is in the UK, we are part of the Napp Pharmaceutical Holdings Limited group of companies, which includes Bard Pharmaceuticals Limited, a Cambridge-based production and supply chain company, which manufactures and exports medicines to over 40 countries worldwide. We are also part of a network of independent associated companies that have a presence around the world, including the USA, China, India, Central and South America, Canada, Australia, Africa and South East Asia.

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”